What is a CD79a lymphoma test?

A CD79a lymphoma test is a type of diagnostic test used to detect the presence of certain types of lymphoma in the body. CD79a is a protein that is found on the surface of B-lymphocytes, which are a type of white blood cell that helps the body fight infections. Lymphoma is a type of cancer that affects the lymphatic system, which is a network of tissues and organs that help the body fight infections and diseases. CD79a lymphoma tests are used to identify the presence of lymphoma cells that are positive for CD79a, which can help doctors determine the best course of treatment for the patient. These tests may be performed on a tissue sample taken from a lymph node or other affected area of the body using a biopsy or other type of procedure. Overall, CD79a lymphoma tests are an important tool in the diagnosis and treatment of lymphoma.

What does a positive CD79a lymphoma test result indicate?

A positive CD79a lymphoma test result indicates the presence of a specific protein called CD79a on the surface of lymphoma cells. CD79a is a marker for B-cell lymphoma, which is a cancer of the immune system that affects B-cells. Therefore, a positive result indicates that a person has B-cell lymphoma. However, a positive result should be confirmed by other diagnostic tests and a thorough medical evaluation by a qualified healthcare professional.

How is a CD79a lymphoma test performed?

A CD79a lymphoma test is typically performed through a biopsy of a lymph node or other affected area of the body. During the biopsy, a small sample of tissue is removed and sent to a laboratory for analysis. The tissue is then examined under a microscope to determine if there are any abnormal cells present that express the CD79a protein, which is a marker for B-cell lymphoma. The test may also include additional laboratory techniques, such as immunohistochemistry or flow cytometry, to further identify and classify the type of lymphoma present. The results of the test can help guide the appropriate treatment plan for the patient.

What other tests are recommended in addition to a CD79a lymphoma test?

In addition to a CD79a lymphoma test, other tests that may be recommended to diagnose lymphoma include a complete blood count (CBC), flow cytometry, immunohistochemistry, and genetic testing such as fluorescent in situ hybridization (FISH). These tests can help determine the specific subtype of lymphoma, as well as provide information on the extent and severity of the disease. A biopsy of the affected tissue may also be necessary to confirm a

diagnosis and guide treatment options. It is important to consult with a healthcare professional for a personalized diagnosis and treatment plan.

Is the CD79a Lymphoma test widely available in ?

Yes, the CD79a Lymphoma test is widely available in . It is a common diagnostic test used to identify lymphoma, a type of cancer that affects the lymphatic system. The test detects the presence of a protein called CD79a on the surface of lymphoma cells. It is commonly used in combination with other diagnostic tests to confirm a lymphoma diagnosis. Many hospitals and diagnostic centers in like CNC PATHLABS offer this test making it a top choice for CD79a testing.

If you are concerned about lymphoma or have symptoms such as enlarged lymph nodes, fever, night sweats, and weight loss, you should consult a doctor who can advise you on the appropriate diagnostic tests.

Are there any special requirements for a CD79a Lymphoma test in ?

To diagnose CD79a lymphoma, a test is required to detect the presence of CD79a protein on the surface of B-cells.

The preparation for a CD79a lymphoma test may vary depending on the type of procedure being performed and the patient's individual needs. In general, patients may be advised to avoid eating or drinking for a certain period of time before the test, especially if they are undergoing a biopsy procedure. Patients should also inform their doctor of any medications they are taking, as some medications may interfere with the test results. Additionally, patients should inform their doctor of any allergies they may have, as some imaging tests may involve the use of contrast dye.

If the patient is undergoing a bone marrow biopsy to test for CD79a lymphoma, they may be advised to avoid taking blood-thinning medications or supplements for a certain period of time before the procedure. Patients may also need to arrange for transportation to and from the testing facility, as some procedures may require sedation. It is important for patients to discuss any concerns or questions they may have with their healthcare provider before the test. By following the proper preparation guidelines, patients can ensure that their CD79a lymphoma test is as accurate and effective as possible.

It is also important to follow any instructions given by the doctor or healthcare provider before the test, such as fasting or refraining from certain medications. After the test, the doctor will interpret the results and provide a diagnosis and treatment plan, if necessary.

Overall, if you suspect that you may have CD79a lymphoma, it is important to consult with a doctor or healthcare provider as soon as possible to receive the appropriate testing and treatment.

Description- CD79a is expressed on all B cells from pre-B cells until plasma-cell stage and is found as intracellular component in plasma cells. It aids in identifying acute leukemia of precursor B-cell type (common ALL), B-cell lymphomas, and some myelomas

Methodology: Immunohistochemistry

TAT: 3-5 days

Specimen Preparation
Collect - tissue /or cell
Specimen Preparation- formal fix (10 % neutral buffered formalin) and paraffin enter specimen (FFPE specimens square measure needed). shield paraffin block or slides from uncontrolled heat. Transport tissue block or five unstained (3-micron thick sections), charged slides during a tissue transport kit. (Min: a pair of slides). If causing precut slides, don't over heat it.
Storage/Transport Temperature- At temperature or cold. Transport it in cooled instrumentation throughout weather.
Unacceptable conditions- i) Specimens submitted with non-marked/tagged tissue sort square measure rejected.
ii) Depleted specimens aren't tested.
Stability- i) Ambient: Indefinitely;
ii) Refrigerated: Indefinitely;
iii) Frozen: Unacceptable